Credit Suisse Ag Athersys, Inc Transaction History

Credit Suisse Ag

  • $101 Billion
  • Q1 2024

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.18 - $0.86 $2 - $11
13 New
13 $0
Q4 2021

Feb 14, 2022
SELL
$0.85 - $1.4 $132,532 - $218,289
-155,921 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$1.33 - $1.77 $5,099 - $6,786
-3,834 Reduced 2.4%
155,921 $207,000
Q2 2021

Aug 16, 2021
BUY
$1.41 - $1.94 $33,573 - $46,193
23,811 Added 17.52%
159,755 $230,000
Q1 2021

May 14, 2021
SELL
$1.61 - $2.77 $305,747 - $526,036
-189,905 Reduced 58.28%
135,944 $244,000
Q4 2020

Feb 12, 2021
SELL
$1.55 - $2.24 $201,393 - $291,045
-129,931 Reduced 28.51%
325,849 $570,000
Q3 2020

Nov 13, 2020
SELL
$1.91 - $3.08 $152,425 - $245,796
-79,804 Reduced 14.9%
455,780 $889,000
Q2 2020

Aug 12, 2020
BUY
$1.97 - $3.98 $990,514 - $2 Million
502,799 Added 1533.63%
535,584 $1.48 Million
Q1 2020

May 13, 2020
BUY
$1.17 - $3.0 $26,573 - $68,136
22,712 Added 225.47%
32,785 $98,000
Q4 2019

Feb 12, 2020
SELL
$1.16 - $1.42 $23,898 - $29,254
-20,602 Reduced 67.16%
10,073 $12,000
Q3 2019

Nov 12, 2019
BUY
$1.21 - $1.65 $3,316 - $4,522
2,741 Added 9.81%
30,675 $41,000
Q2 2019

Aug 14, 2019
BUY
$1.39 - $2.03 $1,695 - $2,476
1,220 Added 4.57%
27,934 $47,000
Q1 2019

May 14, 2019
BUY
$1.39 - $1.71 $10,861 - $13,361
7,814 Added 41.34%
26,714 $40,000
Q4 2018

Feb 13, 2019
BUY
$1.41 - $2.16 $26,649 - $40,824
18,900 New
18,900 $27,000
Q3 2018

Nov 13, 2018
SELL
$1.86 - $2.18 $55,917 - $65,537
-30,063 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$1.76 - $2.79 $13,112 - $20,785
-7,450 Reduced 19.86%
30,063 $59,000
Q1 2018

May 15, 2018
BUY
$1.34 - $2.03 $11,313 - $17,139
8,443 Added 29.04%
37,513 $69,000
Q4 2017

Feb 14, 2018
SELL
$1.65 - $2.45 $62,614 - $92,972
-37,948 Reduced 56.62%
29,070 $53,000
Q3 2017

Nov 14, 2017
BUY
$1.5 - $2.55 $67,896 - $115,423
45,264 Added 208.07%
67,018 $138,000
Q2 2017

Aug 14, 2017
BUY
N/A
21,754
21,754 $33,000

About ATHERSYS, INC

ATHX Quotes by TradingView
  • Ticker ATHX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 305,110,016
  • Market Cap $3.05M
  • Description
  • Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...
More about ATHX
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email